This Notice informs the public that a new therapeutic legislative instrument, the 'Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026', has been made and published on the Federal Register of Legislation website. This instrument applies as a law of Western Australia under the Therapeutic Goods Law Application Act 2024, subject to certain conditions.
Manufacturers, suppliers, and distributors of therapeutic goods in Western Australia are affected as they must now comply with the new 'Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026'. This determination specifies which ingredients are permissible in therapeutic goods, potentially requiring adjustments to product formulations or labelling to ensure compliance.
Search the full archive in the free dashboard, or query programmatically via API.